Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1036020120010010011
ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö
2012 Volume.1 No. 1 p.11 ~ p.20
The Peroxisome Proliferator-Activated Receptor ¥ä Agonist, GW501516, Inhibits Angiogenesis through Dephosphorylation of Endothelial Nitric Oxide Synthase
Kim Jae-Bok

Lee Seok-Hong
Kim Jae-Taek
Abstract
Objective: Peroxisome proliferator-activated receptor ¥ä (PPAR-¥ä) is an ubiquitously expressed nuclear receptor that has been implicated in adipose tissue formation, brain development, and atherosclerosis. Despite mouse studies demonstrating that PPAR-¥ä activation has favorable anti-atherogenic properties by improving systemic lipid profiles, the relationship between PPAR-¥ä agonist and angiogenesis is unknown. We hypothesized that PPAR-¥ä ligands modulate the angiogenesis.

Methods: To test this hypothesis we treated primary cultures of bovine aortic endothelial cells with PPAR-¥ä specific ligand, GW501516 (50-800 nM) for 6 h.

Results: GW501516 dose-dependently decreased nitric oxide production without alteration in endothelial nitric oxide synthase (eNOS) expression. Analysis with phospho-specific antibodies against eNOS demonstrated that GW501516 significantly decreased the phosphorylation of eNOS at Serine1179 (eNOS-Ser1179). Concurrently, GW501516 also decreased the Akt phosphorylation. GW501516 did not affect endothelial cell proliferation or induce apoptosis. However, GW501516 inhibited endothelial cell migration, and tube formation in a high nanomolar concentration. The inhibition of endothelial cell tube formation by GW501516 was prevented by addition of the nitric oxide donor, DETA NONOate (5 ¥ìM). GW501516 was also found to inhibit angiogenesis in vivo in the chicken chorioallantoic membrane assay.

Conclusion: These results provide that high nanomolar range of GW501516 inhibits angiogenesis by a mechanism involving dephosphorylation of eNOS-Ser1179.
KEYWORD
Aortic endothelial cells, GW501516, Nitric oxide, Angiogenesis
FullTexts / Linksout information
Listed journal information